Related Experiment Video
Updated: Dec 28, 2025

09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.3K
Cytometry-based analysis of HLA-G functions according to ILT2 expression
A Jacquier1, C Dumont2, E D Carosella1
1CEA, DRF-Francois Jacob Institute, Hemato-Immunology Research Department, Saint-Louis Hospital, Paris, France; U976 HIPI Unit, IRSL, Paris University, Paris, France.
Human Immunology
|February 22, 2020
Summary
Human Leukocyte Antigen-G (HLA-G) specifically inhibits Natural Killer (NK) and CD8+ T cells expressing its receptor, ILT2. This study introduces a new assay to precisely measure HLA-G
Area of Science:
- Immunology
- Cellular Biology
- Molecular Biology
Background:
- Human Leukocyte Antigen-G (HLA-G) is known to inhibit Natural Killer (NK) and T cell functions via its receptor, ILT2.
- Previous studies often used heterogeneous immune cell populations, potentially underestimating HLA-G's specific inhibitory effects.
- Identifying immune subpopulations sensitive to HLA-G is crucial for understanding its precise role in immune regulation.
Purpose of the Study:
- To develop and validate a novel flow cytometry assay for evaluating HLA-G's functional effects on specific immune cell subsets.
- To precisely assess HLA-G-mediated inhibition of cytotoxic functions (IFN-gamma production and CD107a expression) in ILT2-expressing NK and CD8+ T cells.
- To confirm the specificity of HLA-G inhibition by blocking the HLA-G/ILT2 interaction.
Main Methods:
- Development of a flow cytometry assay to simultaneously analyze multiple immune cell functions (IFN-gamma production, CD107a expression).
- Focus on specific immune subpopulations expressing the HLA-G receptor, ILT2, within NK and CD8+ T cells.
- Comparison of cellular responses in the presence of HLA-G1-expressing target cells and utilization of a blocking antibody against ILT2 to reverse inhibition.
Main Results:
- The assay successfully discriminated between HLA-G1-responding and non-responding cell subsets in a single tube.
- HLA-G was confirmed to specifically inhibit cytotoxic functions in ILT2-positive CD8+ T cells and NK cells, but not in ILT2-negative counterparts.
- Blocking the HLA-G/ILT2 interaction with an anti-ILT2 antibody restored cellular cytotoxicity, validating the specific inhibitory role of HLA-G1.
Conclusions:
- The developed flow cytometry methodology provides a precise and efficient way to investigate HLA-G's immune functions.
- This method allows for fine-tuned analysis of HLA-G effects on specific immune cell lineages and receptor interactions.
- The findings have potential applications in understanding and managing pathological contexts such as cancer and transplantation.

